Immatics (IMTX) Return on Sales Growth (5y) (2024 - 2025)

Immatics (IMTX) Return on Sales Growth (5y) (2024 - 2025) Analysis & Trends

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Oculis Holding AG 67,011.97 Bn 67,011.68 Bn -
2 Nanobiotix 1,908.00 Bn 1,907.94 Bn -
3 Akari Therapeutics 959.56 Bn 959.56 Bn -
4 BeOne Medicines 471.88 Bn 467.08 Bn 1.35 Bn
5 Vertex Pharmaceuticals 122.20 Bn 114.96 Bn 2.59 Bn
6 Regeneron Pharmaceuticals 69.93 Bn 61.17 Bn 3.31 Bn
7 Belite Bio 62.34 Bn 62.34 Bn -
8 Argenx Se 55.85 Bn 50.67 Bn 1.41 Bn
9 Alnylam Pharmaceuticals 37.50 Bn 34.49 Bn 959.66 Mn
10 Immatics 1.12 Bn 571.94 Mn -

Historic Data

Download Data
DateValue
Dec 31, 2025 1.00
Sep 30, 2025 11.00
Jun 30, 2025 -12.00
Mar 31, 2025 -1.00
Dec 31, 2024 4.00
Sep 30, 2024 1.00
Jun 30, 2024 0.00